SFX by Ex Libris Inc.

Title:	A role of nitrite reductase (NirBD) for NO homeostatic regulation in Streptomyces coelicolor A3(2)
Source:	Fems Microbiology Letters [0378-1097] Yukioka, Y yr:2017

Basic

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Jones, Marcus B. "Reducing the Bottleneck in Discovery of Novel Antibiotics." Microbial Ecology 73.3 (2016): 1-10.
description	2.	Xiang, W. "Complete genome sequence of Streptomyces cyaneogriseus ssp. noncyanogenus, the thermotolerant producer of commercial antibiotics nemadectin." Journal of biotechnology. 204: 1-2.
description	3.	Lewis, K. "New approaches to antimicrobial discovery." Biochemical pharmacology 134.Sp. Iss. SI (2016): 87-98.
description	4.	Kurosu, M. "Advances in MRSA drug discovery: where are we and where do we need to be?" Expert opinion on drug discovery 8.9 (2013): 1095-1116.
description	5.	J., Weigelt D. "Towards new business models for R&D for novel antibiotics." Drug resistance updates 14.2 (2011): 88-94.
description	6.	Lewis, K. "Platforms for antibiotic discovery." Nature reviews. Drug discovery 12.5 (2013): 371-387.
description	7.	Roemer, T. "Confronting the challenges of natural product-based antifungal discovery." Chemistry & biology 18.2 (2011): 148-164.
description	8.	"genome sequences." Microbial biotechnology. 7.5: 373-380.
description	9.	Harbarth, S. "Is reduced susceptibility to disinfectants and antiseptics a risk in healthcare settings? A point/counterpoint review." Journal of hospital infection 87.4 (2014): 194-202.
description	10.	Cohen, B E. "Functional Linkage between Genes That Regulate Osmotic Stress Responses and Multidrug Resistance Transporters: Challenges and Opportunities for Antibiotic Discovery." Antimicrobial agents and chemotherapy 58.2 (2014): 640-6.
description	11.	Udumula, V. "Investigation of antibacterial mode of action for traditional and amphiphilic aminoglycosides." Bioorganic and medicinal chemistry letters 23.6 (2013): 1671-1675.
description	12.	Rybak, Jeffrey M. "Current and prospective treatments for multidrug-resistant gram-positive infections." Expert opinion on pharmacotherapy 14.14 (2013): 1919-1932.
description	13.	Koyama, N. "Anti-Infectious Agents against MRSA." Molecules 18.1 (2012): 204-224.
description	14.	Stewart, Eric J. "Growing Unculturable Bacteria." Journal of bacteriology 194.16 (2012): 4151-4160.
description	15.	Sarkar, S. "An overview of tuberculosis chemotherapy - a literature review." Journal of pharmacy & pharmaceutical sciences 14.2 (2011): 148-161.
description	16.	Kesselheim, Aaron S. "Improving antibiotic markets for long-term sustainability." Yale journal of health policy, law, and ethics 11.1 (2011): 101-167.
description	17.	Ekins, S. "In silico repositioning of approved drugs for rare and neglected diseases." Drug discovery today 16.7-8 (2011): 298-310.
description	18.	Freire Moran, L. "Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now." Drug resistance updates 14.2 (2011): 118-124.
description	19.	Woodcock, J. "Precompetitive research: a new prescription for drug development?" Clinical pharmacology & therapeutics 87.5 (2010): 521-523.
description	20.	Lewis, Kim m. "Persister Cells." Annual review of microbiology 64.1 (2010): 357-372.